MapLight Therapeutics, Inc. (MPLT)
7.49
+0.21
(+2.88%)
USD |
NASDAQ |
Nov 10, 10:26
MapLight Therapeutics Cash and Short Term Investments (Quarterly) : 304.72M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 304.72M |
| March 31, 2026 | 310.11M |
| December 31, 2025 | 305.10M |
| September 30, 2025 | 227.17M |
| Date | Value |
|---|---|
| June 30, 2025 | 60.47M |
| March 31, 2025 | 92.26M |
| June 30, 2024 | |
| March 31, 2024 | 179.81M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cullinan Therapeutics, Inc. | 334.54M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 878.78M |